CureMatch Articles & News
CureMatch, Inc., a leader in precision medicine digital decision support solutions, along with authors from esteemed healthcare organizations, released an abstract presenting new research on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment for the 2021 ASCO Annual Meeting, held online June 4-8, 2021. The abstract is titled, “Significance of Scores Generated by a […]
CureMatch, inc. is a digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients….Read More See Full Article Here
Cancer is a devastating disease and treating it can be complex. A single drug is often not adequate to treat many cancer cases. Often, combinations are needed to have and understand data that will help them determine which combination might bets match the genomic or immune abnormalities driving a particular patient’s cancer. CureMatch, as a […]
Oncologists need effective precision medicine tools to navigate the myriad of therapeutic options to best address each patient’s unique tumor profile. Described here is a digital solution, which analyzes tumor data (NGS, other), scores and ranks known and novel matching combinations of cancer drugs with molecular-level precision for decision support. All data was acquired through […]
CureMatch, Inc., a leader in precision digital medicine, announces that Razelle Kurzrock, MD, is presenting insights on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment during the American Association for Cancer Research (AACR) all-virtual Annual Meeting 2021, Week 2, May 17-21, 2021. Board-certified medical oncologist, practicing physician and researcher, Dr. Kurzrock has led the […]